Utilização de balão intragástrico e perda de peso em pacientes em um centro de referência no Rio Grande do Sul
Use of intragastric balloon and weight loss in patients at a reference center in Rio Grande do Sul
Aline Gamarra Taborda Flesch, Richard Ricachenevsky Gurski, Carlos Cauduro Schirmer
Resumo
Objetivo: Estudar a relação entre perda de peso e a utilização de balão intragástrico. Método: Estudo transversal prospectivo desenvolvido com 50 usuários de balão intragástrico em um centro de referência em aparelho digestório no Rio Grande do Sul. Foi calculado o Ãndice de massa corporal (IMC), dividindo-se o peso (quilograma) pela altura (metro) elevada ao quadrado e considerado normal IMC<25; como sobrepeso 25-29,9;IMC 30-34,9 como obesidade grau I; IMC 35-39,9 como obesidade grau II e IMC>40 obesidade grau III, conforme Organização Mundial da Saúde (OMS)/2000. Resultados: Foram avaliados 50 pacientes com estado nutricional entre sobrepeso e obesidade grau III, conforme classificação da OMS/2000. Em relação à porcentagem de perda de peso, observou-se que 46% dos pacientes tiveram uma perda entre 10-15 kg, 24% perda menor que 10 kg, 22% perda entre 15-20 kg e 8% perda maior de 20 kg. Conclusão: Embora a perda média fique entre 15 a 20% do peso inicial, esta perda seja extremamente variável e dependa de vários fatores, como peso inicial, adaptação, volume de preenchimento, disposição emocional para mudanças, adesão ao controle clÃnico e nutricional, grau de atividade fÃsica, metabolismo basal, a motivação e a disciplina para implantar as mudanças são os grandes determinantes deste resultado. Contudo, podemos observar, no presente estudo, evidências sobre a eficácia do tratamento com balão intragástrico em pacientes obesos.
Palavras-chave
Abstract
Objective: To study the relationship between weight loss and use intragastric balloon. Methods: A prospective cross-sectional study was carried out with 50 intragastric balloon users at a reference center in a gastrointestinal tract in RS. The body mass index (BMI) was calculated by dividing the weight (kilogram) by the height (meter) elevated squared and considered normal BMI <25; As overweight 25-29.9; BMI 30-34.9 as obesity grade I; BMI 35-39,9 as obesity grade II and BMI> 40 obesity grade III according to World Health Organization (WHO)/ 2000. Results: Fifty patients with nutritional status between overweight and grade III obesity were evaluated, according to WHO / 2000 classification. Regarding the percentage of weight loss, it was observed that 46% of the patients had a loss between 10-15 kg, 24% a loss less than 10 kg, 22% loss between 15-20 kg and 8% loss greater than 20 kg. Conclusion: Although the average loss is between 15 and 20% of the initial weight, this loss be extremely variable and depends on several factors such as initial weight, adaptation, filling volume, emotional disposition for changes, adherence to clinical and nutritional control, degree of physical activity, basal metabolism, motivation and discipline to implant the changes are the major determinants of this result. However, we can observe in the present study evidence on the efficacy of intragastric balloon treatment in obese patients.
Keywords
Referências
1. World Health Organization - WHO. Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva: World Health Organization; 1998.
2. Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Obesidade. BrasÃlia: Ministério da Saúde; 2006.
3. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al.;American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014;63(25 Pt B):2985-3023.
4. Astrup A, Rössner S. Lessons from obesity management programmes: greater initial weight loss improves long-term maintenance. Obes Rev. 2000;1(1):17-9.
5. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr. 1998;68(4):899-917.
6. Moyer VA.Screening for and management of obesity in adults: U.S. Preventive ServicesTask Force recommendation statement. Ann Intern Med. 2012;157(5):373-8.
7. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766-81.
8. Imaz I, MartÃnez-Cervell C, GarcÃa-Alvarez EE, Sendra- Gutiérrez JM, González-EnrÃquez J. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis.Obes Surg. 2008;18(7):841-6.
9. Sallet JA, Marchesini JB, Paiva DS, Komoto K, Pizani CE, Ribeiro ML, et al. Brazilian multicenter study of the intragastric balloon. Obes Surg. 2004;14(7):991-8.
10. Fernandes M, Atallah AN, Soares BG, Humberto S, Guimarães S, Matos D, et al. Intragastric balloon for obesity. Cochrane Database Syst Rev.2007;24(1):CD004931.
11. Fuller NR, Pearson S, Lau NS, Wlodarczyk J, Halstead MB, Tee HP, et al. An intragastric balloon in the treatment of obese individuals with metabolic syndrome: a randomized controlled study. Obesity (Silver Spring). 2013;21(8):1561-70.
12. Al-Momen A, El-Mogy I. Intragastric balloon for obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg. 2005;15(1):101-5.
13. Genco A, Cipriano M, Bacci V, Cuzzolaro M, Materia A, Raparelli L, et al. Bio Enterics Intragastric Balloon (BIB): a shortterm, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes (Lond). 2006;30(1):129-33.
14. Kotzampassi K, Grosomanidis V, Papakostas P, Penna S, Eleftheriadis E. 500 intragastric balloons: what happens 5 years thereafter? Obes Surg. 2012;22(6):896-903.
15. Herve J, Wahlen CH, Schaeken A, Dallemagne B, Dewandre JM, Markiewicz S, et al. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg. 2005;15(6):864-70.
16. Coutinho WF, Benchimol AK. Obesidade mórbida e afecções associadas. In: Garrido Junior AB, Ferraz EM, Barroso FL, Marchesini JB, Szego T, eds. Cirurgia da obesidade. São Paulo: Atheneu; 2006. p.13-7.
17. World Gastroenterology Organisation. World Gastroenterology Organisation Global Guidelines: Obesity; 2011. [acesso 2016 Jul 20]. DisponÃvel em: http://www.worldgastroenterology.org/ guidelines/global-guidelines/obesity/obesity-english
18. Marchesini JC, Saller JA, Paiva DS. Balão intragástrico. In: Garrido Júnior AB. Cirurgia da obesidade. São Paulo: Atheneu; 2003. p. 61-70.
19. Boletim Brasileiro de Avaliação de Tecnologias em Saúde (BRATS). Cirurgia bariátrica no tratamento da obesidade mórbida, ano III, n. 5; 2008. 11 p.
20. Scheiderman MD. INAMED clinical trial protocol SIB-001 silicone intragástrico ballon: Final Report. In: Sallet JA, ed. Balão intragástrico; 1988. São Paulo: Caminho Editorial; 2001. p.33-41
Submetido em:
18/07/2016
Aceito em:
07/10/2016
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email